We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+9.84%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.1B
AUM Growth
+$1.16B
(+5.5%)
Cap. Flow
-$352M
Cap. Flow
% of AUM
-1.59%
Top 10 Holdings %
Top 10 Hldgs %
19%
Holding
2,132
New
129
Increased
562
Reduced
821
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halliburton
HAL
|
+$43.5M |
| 2 |
Verisk Analytics
VRSK
|
+$39.9M |
| 3 |
KNBE
KnowBe4, Inc. Class A Common Stock
KNBE
|
+$38.6M |
| 4 |
Biogen
BIIB
|
+$38.6M |
| 5 |
VICI Properties
VICI
|
+$34.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$65.7M |
| 2 |
Apple
AAPL
|
+$53.4M |
| 3 |
PayPal
PYPL
|
+$37.7M |
| 4 |
Reinsurance Group of America
RGA
|
+$36.6M |
| 5 |
SLB Ltd
SLB
|
+$31.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.64% |
| 2 | Healthcare | 14.95% |
| 3 | Financials | 14.29% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Real Estate | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Royalty Pharma
RPRX
$26.2B
| $1.99M | 0.01% |
50,470
+12,375
| +32% | +$517K |
|
|
SRCL
627
DELISTED
Stericycle Inc
SRCL
| $1.99M | 0.01% |
39,975
+7,862
| +24% | +$374K |
|
628
Brown-Forman Class B
BF.B
$13.5B
| $1.99M | 0.01% |
+30,352
| New | +$2.06M |
|
629
InvenTrust Properties
IVT
$2.79B
| $1.99M | 0.01% |
84,112
-17,749
| -17% | -$424K |
|
630
iShares MSCI EAFE ETF
EFA
$76.4B
| $1.98M | 0.01% |
30,200
-148,867
| -83% | -$9.33M |
|
631
Phillips 66
PSX
$82.9B
| $1.98M | 0.01% |
19,045
-46
| -0.2% | -$4.71K |
|
632
KBR
KBR
$4.56B
| $1.97M | 0.01% |
37,335
+4,751
| +15% | +$236K |
|
633
Revolve Group
RVLV
$1.85B
| $1.97M | 0.01% |
88,285
-3,900
| -4% | -$93.6K |
|
634
Amcor
AMCR
$21.2B
| $1.96M | 0.01% |
32,971
-6,537
| -17% | -$381K |
|
635
Bank OZK
OZK
$5.63B
| $1.96M | 0.01% |
48,971
+15,122
| +45% | +$649K |
|
636
Jacobs Solutions
J
$16B
| $1.96M | 0.01% |
19,717
+2,187
| +12% | +$215K |
|
637
Eversource Energy
ES
$28.1B
| $1.96M | 0.01% |
23,353
-2,265
| -9% | -$180K |
|
638
MGIC Investment
MTG
$6.47B
| $1.96M | 0.01% |
150,464
+40,068
| +36% | +$527K |
|
639
Principal Financial Group
PFG
$24.3B
| $1.95M | 0.01% |
23,268
+1,925
| +9% | +$165K |
|
640
FTI Consulting
FCN
$5.14B
| $1.95M | 0.01% |
12,266
-1,166
| -9% | -$195K |
|
641
Schneider National
SNDR
$6.17B
| $1.93M | 0.01% |
82,520
-13,804
| -14% | -$323K |
|
642
Neurocrine Biosciences
NBIX
$18.2B
| $1.93M | 0.01% |
16,127
+3,047
| +23% | +$357K |
|
643
Lincoln Electric
LECO
$14.1B
| $1.92M | 0.01% |
+13,318
| New | +$1.87M |
|
644
Ciena
CIEN
$46.8B
| $1.92M | 0.01% |
37,700
-48,658
| -56% | -$2.2M |
|
645
Ryder
R
$9.9B
| $1.92M | 0.01% |
22,953
+1,049
| +5% | +$88.1K |
|
646
Hubbell
HUBB
$24.4B
| $1.91M | 0.01% |
8,150
+78
| +1% | +$18.7K |
|
647
Global Net Lease
GNL
$1.87B
| $1.9M | 0.01% |
151,115
+43,668
| +41% | +$542K |
|
648
Antero Midstream
AM
$10.2B
| $1.9M | 0.01% |
175,890
+47,689
| +37% | +$506K |
|
649
Donaldson
DCI
$10.7B
| $1.9M | 0.01% |
+32,222
| New | +$1.85M |
|
650
Enovis
ENOV
$1.74B
| $1.89M | 0.01% |
35,400
-18,700
| -35% | -$965K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q4 2022 Portfolio in Review
As of Q4 2022, STRS Ohio held 2,132 positions worth $22.1B, up 5.5% from $21B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
STRS Ohio's Q4 2022 filing shows 129 new, 562 increased, 821 reduced and 155 closed positions. Its largest new stake was Biogen: 136,550 shares worth $37.8M. The largest sale was Microsoft, an estimated $65.7M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
- STRS Ohio's largest Q4 2022 buy was Biogen: 136,550 shares worth $37.8M.
- STRS Ohio added most to Halliburton in Q4 2022, an estimated $43.5M increase.
- STRS Ohio's biggest Q4 2022 reduction was Microsoft, cutting an estimated $65.7M.
- STRS Ohio fully exited Abiomed Inc in Q4 2022, selling an estimated $23.7M.
- STRS Ohio's ten largest holdings make up 19% of its $22.1B portfolio in Q4 2022.
- STRS Ohio opened 129 new positions and closed 155 in Q4 2022.
- STRS Ohio's portfolio value rose 5.5% quarter-over-quarter to $22.1B.
Based on STRS Ohio's 13F filing for Q4 2022, filed 26 Jan 2023.